Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer.
Truty MJ, Kendrick ML, Nagorney DM, Smoot RL, Cleary SP, Graham RP, Goenka AH, Hallemeier CL, Haddock MG, Harmsen WS, Mahipal A, McWilliams RR, Halfdanarson TR, Grothey AF. Truty MJ, et al. Among authors: goenka ah. Ann Surg. 2021 Feb 1;273(2):341-349. doi: 10.1097/SLA.0000000000003284. Ann Surg. 2021. PMID: 30946090
Hepatic segmental atrophy and nodular elastosis: imaging features.
Garg I, Graham RP, VanBuren WM, Goenka AH, Torbenson MS, Venkatesh SK. Garg I, et al. Among authors: goenka ah. Abdom Radiol (NY). 2017 Oct;42(10):2447-2453. doi: 10.1007/s00261-017-1164-x. Abdom Radiol (NY). 2017. PMID: 28456818
Molecular radionuclide imaging of pancreatic neoplasms.
Panda A, Garg I, Johnson GB, Truty MJ, Halfdanarson TR, Goenka AH. Panda A, et al. Among authors: goenka ah. Lancet Gastroenterol Hepatol. 2019 Jul;4(7):559-570. doi: 10.1016/S2468-1253(19)30081-0. Lancet Gastroenterol Hepatol. 2019. PMID: 31169124 Review.
Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival.
Panda A, Garg I, Truty MJ, Kline TL, Johnson MP, Ehman EC, Suman G, Anaam DA, Kemp BJ, Johnson GB, Halfdanarson TR, Venkatesh SK, Fidler JL, Goenka AH. Panda A, et al. Among authors: goenka ah. AJR Am J Roentgenol. 2021 Sep;217(3):730-740. doi: 10.2214/AJR.20.24567. Epub 2020 Oct 21. AJR Am J Roentgenol. 2021. PMID: 33084382
PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68 Ga-PSMA-11 PET Using Cyclotron-Produced 68 Ga.
Thompson SM, Suman G, Torbenson MS, Chen ZE, Jondal DE, Patra A, Ehman EC, Andrews JC, Fleming CJ, Welch BT, Kurup AN, Roberts LR, Watt KD, Truty MJ, Cleary SP, Smoot RL, Heimbach JK, Tran NH, Mahipal A, Yin J, Zemla T, Wang C, Fogarty Z, Jacobson M, Kemp BJ, Venkatesh SK, Johnson GB, Woodrum DA, Goenka AH. Thompson SM, et al. Among authors: goenka ah. Hepatol Commun. 2022 May;6(5):1172-1185. doi: 10.1002/hep4.1861. Epub 2021 Nov 15. Hepatol Commun. 2022. PMID: 34783177 Free PMC article.
PET/CT and PET/MRI in neuroendocrine neoplasms.
Rajamohan N, Khasawneh H, Singh A, Suman G, Johnson GB, Majumder S, Halfdanarson TR, Goenka AH. Rajamohan N, et al. Among authors: goenka ah. Abdom Radiol (NY). 2022 Dec;47(12):4058-4072. doi: 10.1007/s00261-022-03516-2. Epub 2022 Apr 15. Abdom Radiol (NY). 2022. PMID: 35426497 Review.
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma.
Abdelrahman AM, Goenka AH, Alva-Ruiz R, Yonkus JA, Leiting JL, Graham RP, Merrell KW, Thiels CA, Hallemeier CL, Warner SG, Haddock MG, Grotz TE, Tran NH, Smoot RL, Ma WW, Cleary SP, McWilliams RR, Nagorney DM, Halfdanarson TR, Kendrick ML, Truty MJ. Abdelrahman AM, et al. Among authors: goenka ah. J Natl Compr Canc Netw. 2022 Sep;20(9):1023-1032.e3. doi: 10.6004/jnccn.2022.7041. J Natl Compr Canc Netw. 2022. PMID: 36075389
Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol.
Karbhari A, Mosessian S, Trivedi KH, Valla F Jr, Jacobson M, Truty MJ, Patnam NG, Simeone DM, Zan E, Brennan T, Chen H, Kuo PH, Herrmann K, Goenka AH. Karbhari A, et al. Among authors: goenka ah. PLoS One. 2023 Nov 27;18(11):e0294564. doi: 10.1371/journal.pone.0294564. eCollection 2023. PLoS One. 2023. PMID: 38011131 Free PMC article.
83 results